HEALTH● ELEVATEDSep 1 · Sep 1, 2026, 5:28 AM
Novartis halts autoimmune CAR-T trials following three patient deaths: WSJ
Seeking Alpha Tech · global
Novartis has halted trials for autoimmune CAR-T therapies after three patient deaths were reported. This action impacts the development of a new treatment type and raises concerns about patient safety in clinical trials.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoPsychology says that acquiring your father's bad habits despite having sworn you wouldn't is not a lack of willpower: they were installed before you could speak, and most men spend forty years fighting against them before finally understanding themClarínHEALTH2h agoCompanies illegally selling unapproved Eli Lily weight loss drug Retatrutide onlineCBS NewsHEALTH2h agoHere's why an Arizona medical examiner is working to track heat-related deathsNPR NewsHEALTH4h agoTexas Abortion Ban Blamed in Pregnant Woman’s Death in LawsuitNYT US